When all tumor cells were counted, numbers of BECLIN1 expressing cells, BNIP3L expressing cells, and LC3B expressing cells were significantly smaller in pCR patients than in non-pCR patients (1.1% vs. 5.8%, 8.5% vs. 18%, and 3.6% vs. 12% respectively, p < 0.05). This evidence concerns the gene BNIP3L and neoplasm.